XML 110 R89.htm IDEA: XBRL DOCUMENT v3.21.2
Equity - Additional Information (Detail) - USD ($)
12 Months Ended
Aug. 31, 2021
Aug. 31, 2020
Aug. 31, 2019
Jan. 06, 2021
Stockholders Equity Note [Line Items]        
Shares repurchased $ 20,000,000.0      
Shares available for grant 1,618,230 465,636 849,522  
Performance based share based compensation and dividend equivalent rights 538,260 469,825 313,540  
Share based compensation, non vested shares 622,528      
Additional shares available for grant 622,528      
Unamortized compensation cost of restricted stock unit grants $ 13,300,000      
Share Repurchase Program - 2014        
Stockholders Equity Note [Line Items]        
Remaining authorized repurchase amount $ 100,000,000.0      
Repurchase program expiration date Jan. 31, 2023      
Repurchase of common stock, shares 0 0    
Selling, Administrative and Cost of Revenue        
Stockholders Equity Note [Line Items]        
Restricted stock compensation expense $ 14,700,000 $ 8,700,000 $ 12,400,000  
Restricted Stock | Minimum        
Stockholders Equity Note [Line Items]        
Vesting period of compensation expense 1 year      
Restricted Stock | Maximum        
Stockholders Equity Note [Line Items]        
Vesting period of compensation expense 3 years      
Unvested Restricted Stock Grants        
Stockholders Equity Note [Line Items]        
Share based compensation, non vested shares 1,023,504 883,933    
Fair value of awards granted $ 18,000,000.0 $ 14,500,000 $ 17,400,000  
2021 Stock Incentive Plan and 2017 Amended and Restated Stock Incentive Plan        
Stockholders Equity Note [Line Items]        
Number of shares reserved for future issuance       1,500,000
2021 Stock Incentive Plan and 2017 Amended and Restated Stock Incentive Plan | Maximum        
Stockholders Equity Note [Line Items]        
Shares available for grant       465,636
Number of common shares outstanding       883,933